EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals

Gianpiero Fasola iD, Maria C Barducci iD, Giacomo Pelizzari iD, Francesco Grossi, Carmine Pinto, Bruno Daniele, Monica Giordano iD, Cinzia Ortega, Rosa Rita Silva, Valeria D Tozzi, Luigi Cavanna, Giuseppe Aprile

The Oncologist · 02.06.2023 · 28 (6) · e324-e330

DOI: 10.1093/oncolo/oyad020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, online erschienen am 27.02.2023. Verfasst von Gianpiero Fasola und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Santa Maria della Misericordia University Hospital, ASUFC, Udine, Italy. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ASUFC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Two main aspects lead the implementation of precision oncology into clinical practice: the adoption of extended genome sequencing technologies and the institution of the Molecular Tumor Boards (MTBs). CIPOMO (Italian Association of Heads of Oncology Department) promoted a national survey across top health care professionals to gain an understanding of the current state of precision oncology in Italy.

Methods

Nineteen questions were sent via the SurveyMonkey platform to 169 heads of oncology departments. Their answers were collected in February 2022.

Results

Overall, 129 directors participated; 113 sets of answers were analyzed. Nineteen regions out of 21 participated as a representative sample of the Italian health care system. The use of next-generation sequencing (NGS) is unevenly distributed; informed consent and clinical reports are managed differently, as the integration of medical, biologic, and informatics domains in a patient-centered workflow is inconsistent. A heterogeneous MTB environment emerged. A total of 33.6% of the responding professionals did not have access to MTBs while 76% of those who have did not refer cases.

Conclusions

NGS technologies and MTBs are not homogeneously implemented in Italy. This fact potentially jeopardizes equal access chances to innovative therapies for patients. This survey was carried out as part of an organizational research project, pursuing a bottom–up approach to identify the needs and possible solutions to optimize the process. These results could be a starting point for clinicians, scientific societies, and health care institutions to outline the best practices and offer shared recommendations for precision oncology implementation in current clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansPrecision MedicineMedical OncologyDelivery of Health CareHealth Personnel

Stichwörter der Autor:innen

healthcare deliveryhealthcare innovation implementationhealthcare management researchmolecular tumor boardsnational surveyprecision oncology implementation

Autor:innen und Institutionen

  • Department of Oncology, Santa Maria della Misericordia University Hospital, ASUFC, Udine, Italy.
  • Collegio Italiano dei Primari Oncologi Medici Ospedalieri (CIPOMO), Genova, Italy.
  • Department of Medicine and Surgery, University of Insubria, ASST dei Sette Laghi, Varese, Italy.
  • Department of Medical Oncology, Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Department of Oncology, Ospedale del Mare, ASL Napoli 1 Centro, Napoli, Italy.
  • Department of Oncology, Ospedale Sant'Anna, ASST-Lariana, Como, Italy.

ORCID-Profile: Gianpiero Fasola, Maria C Barducci, Giacomo Pelizzari, Monica Giordano

Förderung

  • ASUFC

Zitieren

APA

Fasola, G., Barducci, M. C., Pelizzari, G., Grossi, F., Pinto, C., Daniele, B., Giordano, M., Ortega, C., Silva, R. R., Tozzi, V. D., Cavanna, L., & Aprile, G. (2023). Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals. The Oncologist, 28(6), e324-e330. https://doi.org/10.1093/oncolo/oyad020

Vancouver

Fasola G, Barducci MC, Pelizzari G, Grossi F, Pinto C, Daniele B, et al. Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals. The Oncologist. 2023;28(6):e324-e330. doi:10.1093/oncolo/oyad020

BibTeX
@article{Fasola2023,
  author = {Fasola, Gianpiero and Barducci, Maria C and Pelizzari, Giacomo and Grossi, Francesco and Pinto, Carmine and Daniele, Bruno and Giordano, Monica and Ortega, Cinzia and Silva, Rosa Rita and Tozzi, Valeria D and Cavanna, Luigi and Aprile, Giuseppe},
  title = {Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals},
  journal = {The Oncologist},
  year = {2023},
  volume = {28},
  number = {6},
  pages = {e324--e330},
  doi = {10.1093/oncolo/oyad020}
}
Kostenlos starten →